Preliminary experiments point out conolidine might inhibit particular ion channels, decreasing neuronal excitability and restricting soreness signals. This mechanism is particularly pertinent in neuropathic suffering, in which irregular signaling will cause persistent pain. In addition, conolidine appears to impact G protein-coupled receptor (GPCR)